Powertoothbrushing for Treating Gingivitis
9 mars 2021 uppdaterad av: Marquette University
In this three-month interventional clinical trial for the treatment of gingivitis the investigators will assess the use of an oscillating-rotating powered toothbrush in comparison to the use of a manual toothbrush over 12-weeks in the absence of interproximal hygiene.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In this single-masked, parallel-armed, interventional clinical trial for treatment of gingivitis the investigators will assess the use of an oscillating-rotating powered toothbrush in comparison to the use of a manual toothbrush over 12-weeks in the absence of interproximal hygiene.
The primary outcome variable is the change from baseline in the Modified Gingival Index at 2, 4 and 12-weeks from Baseline.
Secondary outcome variables include change from baseline in bleeding on probing as well as change from baseline in the Turesky Modification of the Quigley-Hein Plaque index measuring overnight plaque formation.
There will also be an assessment of single use efficacy in reduction of overnight plaque levels at the baseline visit t
Studietyp
Interventionell
Inskrivning (Faktisk)
55
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Wisconsin
-
Milwaukee, Wisconsin, Förenta staterna, 53233
- Marquette University School of Dentistry
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 65 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
A subject who meets all the following criteria will be eligible to enroll in this study.
- Age range 18 - 65 years
- Routine manual toothbrush user
- A Subject who agrees to use the assigned toothbrush as the only cleaning device for the study duration, refraining from daily interdental cleaning and/ or antiseptic mouthrinsing.
- Mild to moderate gingivitis as measured by A. Modified Gingival Index (MGI) average score of at least 1.2, and / or B. Bleeding on Probing (BOP) of at least 20% of all sites but not more than 50% of sites.
- Probing Pocket Depth (PPD) of 4 mm or lower
- At least 20 natural teeth - scoreable (crowns or bridgework are non-scoreable).
Exclusion Criteria:
Any subject meeting one of the following criteria will not be included in the study.
- Daily user of interdental cleaning devices, such as floss, floss picks, toothpicks, interdental brush, water flossing device
- Regular user of antimicrobial mouthrinses within one week of entry into study
- Professional prophylaxis within one month of entry into the study
- Use of antibiotics within one month prior to the baseline exam
- Signs of moderate to severe periodontitis or caries, categorized as PPD of 5 mm of higher and attachment loss of 3 mm or higher
- Subjects with orthodontic bands and/or dental appliances.
- Participated in an oral care related study in the last 90 days prior to this study
- Pregnant or lactating women
- Patients with a history of significant cardiovascular disease, diabetes, cancer, AIDS, or other organ impairment that would preclude their participation in the study
- Acute/concurrent illness such as hepatitis, herpes simplex infections, influenza, etc.
- History of rheumatic fever, cardiovascular valvular disease, artificial joint replacement or kidney or liver disorders
- Chronic use of steroids; limited use of NSAID's (≤ 325 mg/day)
- Current Smoker (within the last 3 months)
- Other medical or dental conditions that would affect the study
- Inability to commit to all necessary study visits from baseline to 12 weeks
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Powered toothbrush intervention
Subjects will be provided an oscillating rotating powered toothbrush as the experimental intervention, and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
a battery powered oscillating rotating toothbrush will be used for twice daily regular home dental hygiene
Andra namn:
|
|
Inget ingripande: Manual toothbrush
Subjects will be provided a manual toothbrush as the control group and given written instructions on its proper use.
Efficacy of overnight plaque reduction will be assessed at baseline and both gingivitis and plaque reduction will be assessed as change from baseline at 2, 4 and 12 weeks.
Subjects will be given a standard fluoride toothpaste and asked to refrain from daily interproximal plaque control for the duration of the study.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Gingivitis
Tidsram: 12 weeks post-baseline
|
Baseline and 12 weeks post-baseline measures. Proportion of bleeding sites per patient was used as Full mouth BOP Score. The score for each site was either 1 for bleeding and 0 for no bleeding. Following is the full description of each outcome measure reported in the protocol. The Modified Gingival Index3 (MGI) will be measured on six sites - mesio-buccal, buccal, disto-buccal, mesio-lingual, lingual and disto-lingual - of all teeth using a 0-4 scale. Lower score no inflamation and higher severe inflammation. Dental plaque will be evaluated using the Lobene modification4 of the Turesky modification of the Quigley-Hein Plaque Index (PI)5. The score 0 to 5. Lower score means no plaque and higher score increasing plaque.Full-mouth Probing Pocket Depth (PPD) will be measured on the six locations of each tooth (mesial-buccal, buccal, distal-buccal, mesial-lingual, lingual, distal-lingual) using a periodontal probe. |
12 weeks post-baseline
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
5 december 2017
Primärt slutförande (Faktisk)
25 juni 2019
Avslutad studie (Faktisk)
25 juni 2019
Studieregistreringsdatum
Först inskickad
18 december 2017
Först inskickad som uppfyllde QC-kriterierna
18 december 2017
Första postat (Faktisk)
22 december 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
5 april 2021
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
9 mars 2021
Senast verifierad
1 mars 2021
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MarquetteU
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Nej
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Ja
produkt tillverkad i och exporterad från U.S.A.
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .